Tumor necrosis factor α regulates αvβ5 integrin expression by osteoclast precursors in vitro and in vivo

Endocrinology

Volumn 141, Issue 1, 2000, Pages 284-290

  Inoue, Masaru ^a   Ross, F Patrick ^a   Erdmann, Jeanne M ^a   Abu Amer, Yousef ^a   Wei, Shi ^a   Teitelbaum, Steven L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; CYTOKINE; INTEGRIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN P55; PROTEIN SUBUNIT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; STEM CELL;

EID: 0034463105     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.1.7285     Document Type: Article

References (33)

1. Bone marrow-derived mononuclear phagocytes autoregulate mannose receptor expression
2. 3 potentiate bone resorption
3. Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro
4. 3 integrin inhibits osteoclasto-mediated bone resorption in the thyroparathyroidectomized rat
5. 3 integrin knockout mouse is osteosclerotic and has dysfunctional osteoblasts
6. v-associated integrins on murine osteoclast precursors
7. v gene
8. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice
9. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis
10. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro
11. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its p55 receptor
12. Enrichment of generated murine osteoclasts
13. Methods for the purification, assay, characterization and target cell binding of a colony stimulating factor (CSF-1)
14. Mice lacking the tumour necrosis factor receptor I are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
15. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice
16. 5 subunit gene
17. 3 gene promoter
18. 3 gene
19. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 protooncogene) between murine macrophages and B lymphocytes
20. 3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo
21. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts
22. A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5
23. 5. An adhesion receptor for vitronectin
24. Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin
25. Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization
26. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: Regulation by cytokines and bacterial lipopolysaccharide
27. Carbonic anhydrase II mRNA expression in individual osteoclasts under "resorbing" and "nonresorbing" conditions
28. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor
29. Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF
30. Characterization of the Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1
31. Decrease in cytokine production by HIV-infected macrophages in response to LPS-mediated activation
32. Modulation of Na+/K+ exchange potentiates lipopolysaccharide-induced gene expression in murine peritoneal macrophages
33. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level